Association of fish oil supplement use with preservation of brain volume and cognitive function

Alzheimer's & Dementia - Tập 11 - Trang 226-235 - 2015
Lori A. Daiello1,2, Assawin Gongvatana3, Shira Dunsiger4, Ronald A. Cohen3, Brian R. Ott1,2
1Department of Neurology, Warren Alpert Medical School of Brown University, Providence, RI, USA
2Alzheimer's Disease and Memory Disorders Center, Rhode Island Hospital, Providence, RI, USA
3Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA
4Department of Behavior and Social Sciences, The Miriam Hospital, Providence, RI, USA

Tóm tắt

AbstractObjective

The aim of this study was to investigate whether the use of fish oil supplements (FOSs) is associated with concomitant reduction in cognitive decline and brain atrophy in older adults.

Methods

We conducted a retrospective cohort study to examine the relationship between FOS use during the Alzheimer's Disease Neuroimaging Initiative and indicators of cognitive decline. Older adults (229 cognitively normal individuals, 397 patients with mild cognitive impairment, and 193 patients with Alzheimer's disease) were assessed with neuropsychological tests and brain magnetic resonance imaging every 6 months. Primary outcomes included (1) global cognitive status and (2) cerebral cortex gray matter and hippocampus and ventricular volumes.

Results

FOS use during follow‐up was associated with significantly lower mean cognitive subscale of the Alzheimer's Disease Assessment Scale and higher Mini‐Mental State Examination scores among those with normal cognition. Associations between FOS use and the outcomes were observed only in APOE ε4–negative participants. FOS use during the study was also associated with less atrophy in one or more brain regions of interest.


Tài liệu tham khảo

Laditka J.N., 2012, Use of dietary supplements for cognitive health: results of a national survey of adults in the United States, Am J Alzheimers Dis Other Demen, 27, 55, 10.1177/1533317511435662 10.1093/ajcn/85.4.1142 10.1038/sj.ejcn.1602145 10.1212/01.wnl.0000183148.34197.2e 10.1001/archneur.63.11.1545 10.1136/bmj.325.7370.932 10.2174/156720510791050911 N.Sinn C.M.Milte S.J.Street J.D.Buckley A.M.Coates J.Petkov et al.Effects of n‐3 fatty acids EPA v. DHA on depressive symptoms quality of life memory and executive function in older adults with mild cognitive impairment: a 6‐month randomised controlled trial.Br J Nutr2011;1–12 Sydenham E., 2012, Omega 3 fatty acid for the prevention of cognitive decline and dementia, Sao Paulo Med J, 130, 419, 10.1590/S1516-31802012000600013 10.1212/01.wnl.0000324268.45138.86 10.3233/JAD-2010-090940 Stough C., 2012, The effects of 90‐day supplementation with the omega‐3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population, Neurobiol Aging, 33, e821, 10.1016/j.neurobiolaging.2011.03.019 10.1001/jama.2010.1510 10.1016/j.pnpbp.2008.05.015 Terano T., 1999, Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases, Lipids, 34, S345, 10.1007/BF02562338 Mazereeuw G., 2012, Effects of omega‐3 fatty acids on cognitive performance: a meta‐analysis, Neurobiol Aging, 33, e1417, 10.1016/j.neurobiolaging.2011.12.014 10.1001/archneur.63.10.1402 10.1007/s00213-012-2848-0 10.1016/j.neurobiolaging.2009.07.002 Swaminathan S., 2011, Genomic copy number analysis in Alzheimer's disease and mild cognitive impairment: an ADNI study, Int J Alzheimers Dis, 2011 10.1016/j.jalz.2005.06.003 10.1212/WNL.0b013e3181cb3e25 10.1002/jmri.21049 10.1001/archneurol.2010.284 10.2307/2531248 10.2307/2531734 10.1212/WNL.0b013e3182436598 10.1212/WNL.0b013e318249f6a9 10.1212/WNL.0b013e318264e394 10.1016/j.neurobiolaging.2010.04.007 10.1212/WNL.0b013e318245d295 10.1093/ajcn/87.2.449 10.3945/jn.109.119578 10.1016/j.plefa.2012.04.006 M.Hennebelle M.Plourde R.Chouinard‐Watkins C.A.Castellano P.Barberger‐Gateau S.C.Cunnane.Ageing and apoE change DHA homeostasis: relevance to age‐related cognitive decline.Proc Nutr Soc2013;1–7 10.1017/S0007114513001268 10.1212/01.wnl.0000278116.37320.52 10.1093/ajcn/85.4.1103 10.1074/jbc.M111.287078 10.1007/s12035-010-8126-4 10.1371/journal.pone.0015816 10.1017/S0029665111003296